Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 221 (TMEM221) is a protein-coding gene in humans located on chromosome 19 that encodes a predicted single-pass transmembrane protein found in the cell membrane. While its structure suggests membrane localization, there is currently no experimental evidence supporting a defined molecular function, biological pathway, or disease mechanism. The gene has also been referred to by aliases such as Jiraiya and hTMEM221. Some analyses have listed TMEM221 in association with Wolfram syndrome 2, but this relationship is based only on computational predictions and text mining, not experimental validation. TMEM221 is not a well-established drug target, nor is it classified among major molecular families like receptors, ion channels, or enzymes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 221 (TMEM221).